International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers-Reference-Cited by-同舟云学术

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

Published:2008-01-14 Issue:9 Volume:122 Page:2017-2022
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Metcalfe Kelly A.,Birenbaum-Carmeli Daphna,Lubinski Jan,Gronwald Jacek,Lynch Henry,Moller Pal,Ghadirian Parviz,Foulkes William D.,Klijn Jan,Friedman Eitan,Kim-Sing Charmaine,Ainsworth Peter,Rosen Barry,Domchek Susan,Wagner Teresa,Tung Nadine,Manoukian Siranoush,Couch Fergus,Sun Ping,Narod Steven A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium;Ford;Am J Hum Genet,1998

2. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

3. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers;Hartmann;J Natl Cancer Inst,2001

4. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study;Eisen;J Clin Oncol,2005

5. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation;Finch;JAMA,2006

Cited by 302 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Affordable Care Act Provisions on the Racial Makeup of Patients Enrolled at a Deep South, High-Risk Breast Cancer Clinic;Journal of Racial and Ethnic Health Disparities;2024-09-05

2. Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy;Familial Cancer;2024-06-21

3. Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape;Current Oncology Reports;2024-06-01

4. Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: Mastectomy versus conservative treatment;Journal of Gynecology Obstetrics and Human Reproduction;2024-05

5. A cost-benefit analysis of genetic screening test for breast cancer in Iran;BMC Cancer;2024-03-01